This hypothesis is supported by findings of altered expression of genes encoding metabolic pathways in Type II diabetic patients [15] such as, insulin-induced activity of IR, IRS, PI3K, AKT and GLUT4 have been reported to be reduced in Type II diabetes [16–19]. The gene discussed is INS; the disease is type 2 diabetes mellitus.